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Edited by Francesc PosasAbstract The protein kinase COT/Tpl2 is activated by interleu-
kin-1 (IL-1), TNFa and lipopolysaccharide, and its activation by
these agonists involves the IjB kinase b (IKKb) catalysed phos-
phorylation of the p105 regulatory subunit. Here, we show that
COT activation also requires catalytic subunit phosphorylation,
since IL-1b induced a 5–10-fold activation of a COT mutant un-
able to bind p105. Activation was paralleled by the phosphoryla-
tion of Thr290 and Ser62 and unaﬀected by the IKKb inhibitor
PS1145 at concentrations which prevented the degradation of
IjBa. Mutagenesis experiments indicated that COT activation
is initiated by Thr290 phosphorylation catalysed by an IL-1-
stimulated protein kinase distinct from IKKb, while Ser62
phosphorylation is an autophosphorylation event required for
maximal activation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The classical MAP kinase cascade is most commonly
thought of as a signalling pathway switched on by growth fac-
tors and triggered by the Ras-induced activation of the protein
kinase Raf. In this pathway, Raf activates mitogen-activated
protein (MAP) kinase kinase-1 (MKK1, also called MEK1),
which then activates two MAP kinase family members, termed
extracellular signal regulated kinases 1 and 2 (ERK1, ERK2).
However, activation of this pathway by lipopolysaccharide
(LPS) [1–3] or the proinﬂammatory cytokines tumour necrosis
factor a (TNFa) [4] and interleukin-1 (IL-1) [5] does not re-
quire Raf, but a distinct MAP kinase kinase kinase, termed
COT or Tpl2. The activation of COT is required for the
LPS-induced production of TNFa in macrophages [1] and
COT-deﬁcient mice are protected against experimentally in-
duced inﬂammatory bowel disease [6]. For this reason, COT
has become an interesting target for the development of drugs
to treat chronic inﬂammatory diseases.
Recently, signiﬁcant progress has been made in understand-
ing how COT is activated by LPS or TNFa. In unstimulated
cells, COT is inactive because it is complexed to a regulatory
subunit, termed p105 [7], a protein which is also the precursor*Corresponding author. Fax: +44 1382 223778.
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doi:10.1016/j.febslet.2006.06.004of p50, a subunit of the NFjB transcription factor. LPS or
TNFa induce the activation of IjB kinase b (IKKb), which
then phosphorylates the C-terminus of p105, triggering the
degradation of p105 and release of the active catalytic subunit
[8,9]. However, these ﬁndings did not exclude the possibility
that the activation of COT also requires the modiﬁcation of
another component of the COT complex. Indeed, there is evi-
dence that, in order to be catalytically active, the ‘‘activation
loop’’ of the COT catalytic subunit may need to be phosphor-
ylated. Two laboratories reported that, when expressed in hu-
man embryonic kidney 293T cells [10,11] or human monocytes
[12], wild type COT or a catalytically inactive mutant of COT
was phosphorylated at Thr290. Incubation of the wild type en-
zyme with a protein phosphatase decreased COT activity [10],
while the mutation of Thr290 to Ala prevented COT from acti-
vating the classical MAP kinase pathway [10,11]. These experi-
ments suggested that the phosphorylation of Thr290 was
catalysed by a protein kinase distinct from COT/Tpl2 and that
this may be essential for activity. However, while one labora-
tory reported that the phosphorylation of COT at Thr290 did
not increase in response to LPS [10], the other reported that
COT expressed in the RAW264.7 macrophage cell line did be-
come phosphorylated at Thr290 in response to LPS and in par-
allel with the rise in COT activity [11]. Phosphorylation of
the COT catalytic subunit was also reported to facilitate its re-
lease from p105 [12]. Moreover, like phosphorylation of the
C-terminus of p105, phosphorylation of the COT catalytic
subunit at Thr290 was reported to be catalysed by IKKb, be-
cause it was prevented by high concentrations of PS1145, a cell
permeant inhibitor of IKKb [11].
Here we demonstrate, in HEK 293 cells stably expressing the
IL-1 receptor, that IL-1b induces the phosphorylation of
Thr290 and activation of COT[30–397], a truncated form of
the catalytic subunit unable to bind to p105. The phosphoryla-
tion of COT[30–397] was unaﬀected by PS1145 at concentra-
tions which block the degradation of IjB. We also show that
IL-1 induces the phosphorylation of COT[30–397] at Ser62, as
well as at Thr290, and present evidence that this is an autophos-
phorylation event required for the maximal activation of COT.2. Materials and methods
2.1. DNA cloning, mutagenesis, protein expression and puriﬁcation
DNA encoding COT[30–397] was ampliﬁed from IMAGE EST
6199903 (Geneservice.co.uk) using the GC Rich PCR System (Roche)
with the oligonucleotides GCGGATCCATGGAAAATCTTT-
ATGCAAGTGAAGAGCCAGC and GCGAATTCTTAGCGTG-blished by Elsevier B.V. All rights reserved.
M.J. Staﬀord et al. / FEBS Letters 580 (2006) 4010–4014 4011GCTGATCCTCTCTGGG. The resulting fragment was ligated into
pCR2.1 (Invitrogen) and sequenced. pCR2.1-COT[30–397] was di-
gested with BamH1/ Not1 and ligated into the same sites in EBG6P
to produce EBG6P-COT[30–397] encoding the GST-fusion protein
or in pFBHTb to produce pFBHTb-COT[30–397] encoding the His6-
tagged protein which was expressed in insect Sf21 cells and puriﬁed
by aﬃnity chromatography on nickel-nitrilo-triacetate agarose. The
S62A and T290A mutations were made following the Stratagene
Quickchange Site Directed Mutagenesis protocol.
2.2. Antibodies
The peptides KDLRGT*EIYMS (where T* is phosphothreonine)
and DERSKS*LLLSG (where S* is phosphoserine), corresponding
to residues 285–295 and 57–67 of human COT, respectively, were cou-
pled to both bovine serum albumin and keyhole limpet haemocyanin
and injected into sheep at Diagnostics Scotland (Edinburgh, UK).
The antibodies were aﬃnity puriﬁed on CH-Sepharose to which the
relevant phosphorylated peptide had been coupled covalently, and
used for immunoblotting at 1 lg/ml. Antibodies that recognize IjBa,
MAP kinase-activated protein kinase-2 (MAPKAP-K2) were from
Cell Signalling Technologies. Antibodies that recognise GST were gen-
erated by the Division of Signal Transduction Therapy, University of
Dundee, while rabbit, mouse and sheep-speciﬁc secondary antibodies
conjugated to horseradish peroxidase were from Pierce.
2.3. Cell culture, transfection and lysis
Human embryonic kidney (HEK) 293 cells stably expressing the IL-
1 receptor, termed IL1-R cells (generously provided by Tularic Inc.,
USA), were cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
with 10% (v/v) foetal calf serum (FCS). Cells were transfected at 40–
50% conﬂuency using polyethyleneimine and 7.5 lg DNA for each vec-
tor. After 24 h the medium was replaced with DMEM without or with
serum and then left for 16 h before stimulation with 5 ng/ml IL-1b
(Invitrogen). Cells were lysed in ice cold lysis buﬀer (50 mM Tris/
HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovana-
date, 10 mM sodium b-glycerolphosphate, 50 mM sodium ﬂuoride,
5 mM sodium pyrophosphate, 0.27 M sucrose, 1% (v/v) Triton
X-100, 0.1% (v/v) 2-mercaptoethanol, and Complete proteinase
inhibitor cocktail (Roche: one tablet per 50 ml buﬀer)). Lysates wereFig. 1. MS analysis of COT expressed in insect cells. His6-tagged COT[30–3
nickel-nitrilo-triacetate agarose, digested with trypsin and analysed by LC-MS
denotes ion intensity in counts per second (cps) and the x-axis shows mass/cha
its position in the amino acid sequence of COT and the vertical arrows show
phosphorylation. The ion denoted with an asterisk was determined to be a ccentrifuged at 13000 · g for 10 min at 4 C and the supernatants used
immediately or snap frozen in liquid nitrogen and stored in aliquots at
20 C until use.
2.4. Assay of COT activity
Cell extract (2 mg protein) from IL-1 R cells expressing GST-
COT[30–397] was incubated for 2 h at 4 C with 20 ll glutathione Se-
pharose 4B (Amersham Pharmacia Biotech). After washing in lysis
buﬀer containing 150 mM NaCl, lysis buﬀer plus 300 mM NaCl, lysis
buﬀer plus 150 mM NaCl and then 50 mM Tris/HCl, pH 7.5, 0.1 mM
EGTA and 0.1% (v/v) 2-mercaptoethanol, COT bound to glutathione-
Sepharose was assayed as described previously for Raf [13]. In this
two-step assay, COT (or Raf) is assayed by its ability to activate
MKK1, which is then assayed by the activation of ERK2 (also called
p42 MAPK). The active ERK2 is then assayed by the phosphorylation
of myelin basic protein.3. Results and discussion
3.1. Identiﬁcation of Ser62 as a phosphorylation site on COT
COT[30–397] was expressed in insect Sf21 cells in a catalyt-
ically active form and subjected to mass spectrometry to iden-
tify sites of phosphorylation. This analysis revealed a striking
phosphorylation of Ser62, a site that had not been reported
previously, with more minor phosphorylation at several other
novel sites, namely Ser125, Ser141 and Ser344 (Fig. 1). We
therefore raised phospho-speciﬁc antibodies that were capable
of recognising COT phosphorylated at Ser62. We also raised
antibodies against the previously reported phosphorylation
site at Thr290 (see Section 1), which recognised the insect
cell-expressed protein in immunoblotting experiments. Recog-
nition by the phospho-Thr290 antibody was abolished after
incubation of COT[30–397] with the phage kgt10 phosphatase
(data not shown). This showed that insect cell-expressed COT97] was expressed in Sf21 cells, puriﬁed by aﬃnity chromatography on
with precursor 79 scanning on a 4000 Q-TRAP system [14]. The y-axis
rge (m/z). The numbers above each phosphoserine residue (pS) refer to
the m/z values corresponding to the peptides which contain the sites of
ontaminant.
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Fig. 3. Eﬀect of IL-1b on the activation of wild-type and mutant forms
of COT[30–397] expressed in IL-1R cells DNA encoding GST-
COT[30–397] or mutants of this construct in which Thr290 or Ser62
were mutated to Ala, were transfected into IL-1R cells. After 24 h, the
cells were serum-starved for a further 16 h in DMEM, then either lysed
(time zero) or stimulated for 15 or 30 min with 5 ng/ml IL-1b.
Following cell lysis, the GST-COT[30–397] was puriﬁed from the
extracts on glutathione Sepharose and assayed (see Section 2). The
results are shown ±S.D. for three diﬀerent experiments.
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tected by mass spectrometry.
3.2. Eﬀect of IL-1 on the activation and site-speciﬁc
phosphorylation of COT
A vector expressing GST-COT[30–397] was transfected into
HEK 293 cells that stably express the IL-1 receptor (IL-1R
cells) and the GST-COT puriﬁed from the extracts as described
under Section 2 and assayed for activity before (+) and after
() serum starvation for 16 h. These experiments showed that
COT was active (Fig. 2A) and phosphorylated at both Ser62
and Thr290 (Fig. 2B) when the cells were grown in serum,
and that activity and phosphorylation at both sites was greatly
decreased after depriving the cells of serum. All subsequent
experiments to study the eﬀect of IL-1 were therefore were car-
ried out after 16 h serum starvation.
Stimulation of serum-starved cells with IL-1 induced a 5–10-
fold increase in the activity of COT (Fig. 3). The time required
for maximal activation was 15 min in some experiments and
30 min in others. IL-1 also induced the phosphorylation of
COT at both Ser62 and Thr290 over the same time period
(Fig. 4A).
In order to investigate the potential contribution of Ser62
and Thr290 to the activation of COT, these two residues were
mutated individually to Ala and each COT[30–397] mutant
transfected into the IL-R cells. IL-1 activated the Ser62Ala
mutant of COT to about 60% of the level observed with un-
mutated COT[30–397] (Fig. 3) and the Ser62Ala mutation
did not aﬀect the IL-1-induced phosphorylation of Thr290
(Fig. 4B). In contrast, the mutation of Thr290 to Ala abolishedGSTpT290
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Fig. 2. Serum starvation inactivates COT[30–397] in IL-1R cells.
DNA encoding wild-type (WT) GST-COT[30–397] was transfected
into IL-1R cells. After 24 h, the transfection medium was replaced with
DMEM without or with 10% serum and the cells were left for a further
16 h before lysis. COT was puriﬁed by chromatography on glutathi-
one-Sepharose from 2 mg of cell lysate protein, and either assayed for
activity (A) or recovered from the beads using LDS, subjected to SDS–
PAGE on 4–12% gradient gels, transferred to a PDVF membrane and
immunoblotted with phospho-speciﬁc antibodies that recognise COT
phosphorylated at Thr290 or Ser62 using the ECL detection system
(Amersham) (left-hand panels in B). The right-hand panels in B show
the same membranes stripped and reprobed with anti-GST.the activation of COT[30–397] (Fig. 3) and also prevented the
phosphorylation of Ser62 (Fig. 4C). These results suggested
that the initial activation of COT[30–397] may result from
the phosphorylation of Thr290 and that the phosphorylation
of Ser62 is a subsequent autophosphorylation event that is re-
quired for maximal activation.
It should also be noted that, after the mutation of Ser62 to
Ala, the mutated COT was not recognised by the anti-Ser62
phospho-speciﬁc antibody, and that after the mutation of
Thr 290 to Ala, the mutant enzyme was not recognised by
the anti-Thr290 phospho-speciﬁc antibody, establishing the
speciﬁcities of both antibodies (Fig. 4B and C).
It had been reported that high (50 lM) concentrations of PS
1145, a small cell permeant inhibitor of IKKb, prevented the
phosphorylation of COT at Thr290, suggesting that IKKb
catalyses the phosphorylation of Thr290 in RAW cells [11].
However, we found that the IL-1-induced phosphorylation
of Thr290 in IL-1R cells was unaﬀected at 15 lM PS 1145, a
concentration that abrogated the IKKb-catalysed phosphory-
lation and degradation of IjBa (Fig. 5). It has been shown pre-
viously by others that 10 lM PS 1145 is suﬃcient to prevent
the LPS-induced degradation of p105, the activation of COT
and the phosphorylation of ERK1 and ERK2 ([8], M.Water-
ﬁeld personal communication). At the higher concentration
of PS 1145 (50 lM), we found that this compound inhibited
other signalling pathways, such as the JNK and p38a MAP ki-
nase pathways (data not shown). Taken together, these results
indicate that the previously reported suppression of Thr290
phosphorylation at high concentrations of PS1145 (which we
have also observed) may be a non-speciﬁc eﬀect, unrelated to
the inhibition of IKKb. We therefore conclude that the phos-
phorylation of COT[30–397] at Thr290 is catalysed by an IL-
1b-stimulated protein kinase, distinct from IKKb, that has
yet to be identiﬁed, and that the activation of the COT com-
plex requires the phosphorylation of the COT catalytic sub-
unit, as well as the IKKb-catalysed phosphorylation of p105.
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Fig. 4. Eﬀect of mutation of Thr290 or Ser62 on the phosphorylation of COT[30–397] in IL-1R cells. (A) The experiment was carried exactly as
described in the legend to Fig. 3, except that the GST-COT[30–397] was released from glutathione-Sepharose with LDS, subjected to SDS–PAGE,
transferred to PDVF membranes and immunoblotted with antibodies that recognise COT phosphorylated at Thr290 or Ser62, then stripped and
reprobed with anti-GST. (B,C) The experiments were carried out as in A, except that the vectors encoding the Ser62Ala or Thr290Ala mutants of
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Fig. 5. The IKKb inhibitor PS1145 does not inhibit the IL-1 induced
phosphorylation of COT[30–397] at Thr290 in IL-1R cells at a
concentration that prevents the degradation of IjBa. DNA encoding
GST-COT[30–397] was transfected into IL-1R cells. After 24 h the
cells were serum starved for 16 h in DMEM, then incubated for
90 min without or with 15 lM PS 1145, before stimulation for 15 min
with 5 ng/ml IL-1b. Following cell lysis, the GST-COT[30–397] was
puriﬁed from the cell extracts on glutathione Sepharose and
immunoblotted as in Fig. 4 with the antibody that recognises COT
phosphorylated at Thr290 (pT290) (upper left-hand panel) and with
an anti-GST antibody to show the amount of GST-COT (upper
right-hand panel). Aliquots of the cell extract (30 lg protein) were
also immunoblotted with antibodies that recognise IjBa (lower left-
hand panel) and MAPKAP-K2 (as a loading control, lower right-
hand panel).
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